MED241115P80000
- 28.90
- 0.000.00%
Medifast Newsroom
Earnings Preview: Medifast to Report Financial Results Post-market on November 04
$Medifast(MED.US)$ is scheduled to release its financial results post-market on November 04 ET. Earnings PreviewAnalysts estimate $Medifast(MED.US)$ to post revenue of USD134.15M for 2024Q3, down 43.1
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
Shareholders in Medifast (NYSE:MED) Are in the Red If They Invested Three Years Ago
Medifast (MED): A Bull Case Theory
Personal Care Stocks Q2 Results: Benchmarking Medifast (NYSE:MED)
Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
Express News | Medifast Inc Shares Hit Session High in Late Afternoon, Last up 7.3% at $19.67
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
Medifast's (NYSE:MED) Soft Earnings Don't Show The Whole Picture
Express News | Medifast Inc : Stephens Cuts Target Price to $18 From $24
D.A. Davidson Maintains Medifast(MED.US) With Sell Rating, Cuts Target Price to $16.5
D.A. Davidson analyst Linda Bolton Weiser maintains $Medifast(MED.US)$ with a sell rating, and adjusts the target price from $17.5 to $16.5.According to TipRanks data, the analyst has a success rate
Analysts Offer Insights on Consumer Cyclical Companies: Penn National Gaming (PENN), Lincoln Edu (LINC) and Medifast (MED)
D.A. Davidson Sticks to Their Sell Rating for Medifast (MED)
Earnings Call: Medifast Eyes Growth With GLP-1 Products Amid Revenue Dip
Medifast (MED) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
Earnings Call Summary | Medifast(MED.US) Q2 2024 Earnings Conference
Express News | Medifast Inc : D.a. Davidson Cuts Target Price to $16.5 From $17.5
Medifast, Inc. (MED) Q2 2024 Earnings Call Transcript
Medifast | 10-Q: Q2 2024 Earnings Report